Deargen

Deargen

IT 서비스 및 IT 컨설팅

AI-First Pharmatech Company. We are exploring sequence-based drug discovery and development.

소개

AI-First Pharmatech Company, a game-changer in AI-driven drug developing process. We discover, design and develop the drug by sequence-based end-to-end AI solution. - By integrating advanced AI technology and experts experience, Deargen is committed to discovering, designing and developing the best possible drugs in the fastest and most effective way. - Deargen specializes in discovering the Hit/Lead compound regardless of the target protein’s 3D information by first applying transformer technology into the pharmaceutical field. - Deargen members are experts in drug development, deep learning, software, biology, computational & medicinal chemistry, etc., for target discovery to lead optimization. Our end-to-end solution of AI platform allows saving time and cost compared to the traditional methods of drug discovery and development. - Deargen assures you that we can meet your unmet scientific needs by providing technology and experiences to develop new drugs.

웹사이트
https://deargen.me/
업계
IT 서비스 및 IT 컨설팅
회사 규모
직원 51-200명
본사
Daejeon
유형
비상장기업
설립
2016

위치

  • 기본

    Administration B/D, 193, Munji-ro, Yuseong-gu

    KR Daejeon

    길 보기
  • Dongwon F&B, 60, Mabang-ro, Seocho-gu

    KR seoul

    길 보기
  • 4185 Silver Peak Pkwy

    US Georgia Suwanee 30024

    길 보기

Deargen 직원

비슷한 페이지

자금조달

Deargen 총 3라운드

마지막 라운드

시리즈 B

US$16,582,992.00

크런치베이스에서 자세히 알아보기